TP53 and lung cancer: It is known that B[a]P epoxide adducts can be derived from LOH of the p53 gene in bronchial epithelial cells, a mutation associated with lung cancer, and greater expression of the AhR and of xenobiotic metabolism enzymes that predispose the formation of reactive metabolites [85,86].